Effects of thyroid hormone on a-actin and myosin heavy chain gene expression were compared in ventricle, soleus, and extensor digitorum longus muscles of hypothyroid rats. Changes in mRNA content were analyzed using synthetic oligonucleotide probes complementary to the unique 3' untranslated regions of four striated myosin heavy chain mRNAs and cardiac and skeletal muscle a-actin mRNAs. The results indicate that daily treatment with 3,5,3'-triiodo-L-thyronine (2 /n.g/100 g body weight) increased a-myosin heavy chain mRNA content in heart muscle by 500% and decreased /3myosin heavy chain mRNA by 65% within 48 hours. /3-mRNA in extensor digitorum longus was decreased by 60% at 48 hours while in soleus, /3-mRNA levels were not affected by 9 weeks of treatment. Fast Ha mRNA was present in small amounts in hypothyroid soleus and increased by 150% and 200% after 7 and 9 weeks of thyroid hormone administration, respectively. Fast lib mRNA also was found in hypothyroid soleus and a small increase (60%) was observed after 1 day of treatment. In extensor digitorum longus, Fast lib mRNA increased by 200% and Fast Ha mRNA decreased by 50% after 1 week of treatment. When larger daily doses of thyroid hormone (15 /n.g/100 g body weight) were administered, similar changes in mRNA levels were observed, except that /3-mRNA content of soleus muscle was decreased slightly (25%). Expression of the cardiac form of a-actin was induced transiently in ventricle, but the skeletal form of a-actin mRNA in soleus and extensor digitorum longus did not change significantly after thyroid hormone treatment. Skeletal a-actin mRNA was not found in ventricle, and cardiac a-actin mRNA was not detected In skeletal muscles. Thus, cardiac a-actin mRNA levels are transiently stimulated in ventricle by thyroid hormone treatment while all of the myosin heavy chain genes expressed in adult striated muscles are affected in a complex, tissue-specific manner. (Circulation Research 1986;59:194-201) M YOSIN heavy chain (MHC) isoforms in striated muscles are encoded by a highly conserved multigene family. 1 At least six MHCs are known to be expressed in striated muscles of the rat, including embryonic and neonatal skeletal muscle forms, fast oxidative glycolytic (Fast Ha), and fast glycolytic (Fast lib) skeletal forms, and two cardiac types, a and /3. The /3-MHC form is also expressed in slow skeletal muscles. 2 Although the coding regions of these genes show a high degree of homology, the 3'untranslated sequences are not as closely conserved. 3 The MHC genes show distinct patterns of tissuespecific expression that are hormonally and developmentally regulated. 2 " 7 The effects of thyroid hormone on expression of a-and /3-MHC forms in the ventricle have been studied most extensively (see review in Morkin et al. 8 ). In the rat ventricle, there are three myosin isoforms, referred to as V,_ 3 , in order of decreasing electrophoretic mobility on nondenaturing
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Alterations in myosin composition of various muscles may be physiologically significant, since the relative proportions of the isoforms seem to be directly related to the intrinsic speed of contraction. 13 14 Thyroid hormone treatment has been shown to increase the proportion of the V, isoenyzme and the maximal velocity of shortening in isolated ventricular muscle (see review in Morkin et al). 8 Similarly, in skeletal muscle the shortening velocity of whole muscles and individual fibers has been shown to be closely related to the proportion of fast-to-slow MHCs. [15] [16] [17] Alterations in thyroid status also have been reported to effect myosin isoforms in skeletal muscles. An increase in the percentage of fast (Type II) fibers in both fast-and slow-twitch skeletal muscles has been found after thyroid hormone administration. 161819 Con-versely, slow (Type I) fibers have been shown to increase in rat skeletal muscles after thyroidectomy. 18 Furthermore, during the development of skeletal and cardiac muscles the normal transition of embryonic to adult MHC isoenzyme patterns has been shown to be inhibited by hypothyroidism and accelerated by hyperthyroidism. 20 ' 21 The question naturally arises as to whether thyroid hormone produces these changes in skeletal muscles by altering the expression of MHC genes as is observed in ventricular muscle. a-Actins also represent a family of highly conserved proteins. In the adult rat, two major isoforms, a-cardiac and a-skeletal actin, are expressed in heart and skeletal muscles, respectively. The hearts of neonatal rats have been known to contain significant amounts of a-skeletal actin mRNA, and conversely, a-cardiac actin has been shown to be expressed in neonatal skeletal muscle. 22 Thus, like the MHC gene family, the a-actin family appears to be developmentally regulated in the rat, but it is not clear whether thyroid hormone plays a role in regulating the expression of these genes.
In this report, we have compared the effects of thyroid hormone treatment at two dosage levels on MHC and a-actin mRNA expression in ventricle, soleus, and extensor digitorum longus (EDL) muscles of the rat. To facilitate analysis of these effects, we have developed a rapid, simple dot-blot assay using synthetic [ 32 P]-labelled oligonucleotide DNA probes constructed to be complementary to the unique 3' flanking sequences of four of the six major striated muscle myosin mRNAs and the two sarcomeric a-actin mRNAs of the rat. The results indicate that expression of all of the MHC genes is regulated by thyroid hormone in a highly complex, tissue-specific manner. Analysis of the expression of the a-actin genes after administration of 3,5,3'-triiode-L-thyronine (T 3 ) shows a transient increase in a-cardiac actin mRNA content in the ventricle, but no a-actin isoform transitions are observed in ventricle, EDL, or soleus muscles.
Materials and Methods

Animal Experiments
Thyroidectomized male Sprague-Dawley rats weighing approximately 200 g were obtained commercially and maintained on rat chow. Methimazole (200 mg/1) and calcium gluconate (1.5 g/1) were added to the drinking water. Animals were weighed twice weekly and considered to be hypothyroid only after cessation of growth was observed. Stock solutions of L-T 3 were prepared in 0.1 N NaOH at a concentration of 2 mg/ml and diluted in physiological saline prior to administration. Animals received either 2 or 15 /Ag Tj/100 g body weight daily by intraperitoneal injection. The lower dose was found to restore normal growth to thyroidectomized rats and to result in a euthyroid myosin isoenzyme pattern. 23 During treatment with the higher dosage, normal increases in body weight were also observed. Animals were killed by decapitation and the tissues quickly removed and placed in cold phosphate buffered saline. The tissues then were weighed, and RNA was prepared.
Isolation of RNA
Total cellular RNA was isolated from ventricular and skeletal muscles using the guanidinium isothiocyanate-hot phenol method. 24 All plastic and glassware was pretreated with 0.1 % diethylpyrocarbonate at 37° C for 30 minutes and autoclaved. The final RNA pellet was resuspended in distilled H 2 O and stored at -70°C.
Preparation of Synthetic Probes
Synthetic oligonucleotide probes 20 bases in length were prepared in an Applied Biosystems DNA Synthesizer (Model 380A) and purified by electrophoresis. The probes were labelled at the 5' end using T 4 polynucleotide kinase 23 to a specific activity of 2 to 4 x 10 8 cpm//xg. Labelled probe was separated from unincorporated [•y-32 P]-ATP by filtration through small columns of Bio-Gel P-2 (Bio-Rad), precipitated in 70% ethanol at -70° C, and then resuspended in deionized
The sequences of the four MHC oligonucleotide probes used in this study have been reported earlier. 7 The sequences of the two additional probes used here are as follows (5' to 3'): a-cardiac actin, TGCACGTGTGTAAACAAACT; and a-skeletal actin, GCAACCATAGCACGATGGTC. 22 M 
Dot Blot Assays
RNA samples at a concentration of 0.5 to 2.0 mg/ml were denatured by heating at 65°C for 15 minutes and cooled on ice. Aliquots of 4 \x\ were spotted in triplicate directly onto dry nitrocellulose filters that had been pretreated with 3.0 M NaCl, 0.3 M Na citrate as described earlier. 27 After spotting, filters were baked at 80°C for 2 hours. Denaturation of RNA samples by glyoxylation or formaldehyde treatment prior to spotting did not result in any increase in the sensitivity of the assay (data not shown). Prehybridizations, hybridizations, and wash steps were carried out essentially as described earlier, 28 with some modifications. Prior to prehybridization, the filters were wet in deionized H 2 O and prehybridized at 45°C for at least 8 hours in buffer containing 0.1% bovine serum albumin, 0.1% polyvinylpyrrolidone, 0.1% sodium dodecyl sulfate (SDS), 0.1 % Ficoll, 10% dextran sulfate, 0.9 M NaCl, 0.18 M Tris-HCl, pH 8, 6 mM EDTA, and 0.5% Nonidet P-40. Hybridization was carried out by heating the probe-containing solution to 65° C for 10 minutes and adding it directly to the prehybridization fluid at a concentration of approximately 3 ng/ml in a volume of at least 5 ml per bag and about 2 ml per filter. After hybridization for 18-20 hours the filters were washed with four 10-minute changes of 0.9 M NaCl, 0.09 M sodium citrate at room temperature (22-23°C). A final 1-minute wash at 50° C in the same solution was performed, and the filters were allowed to air dry. Filters were wrapped in plastic and autoradiography was carried out with intensifying screens at -70° C for 4 hours to 2 days. Afterwards, individual spots were cut from the filters and the radioactivity was determined by liquid scintillation counting in Aquasol (New England Nuclear Corp., Boston, Mass.). Aliquots of total RNA prepared from rat liver were spotted at the same concentrations as the muscle RNAs. These spots were counted and the values were considered to represent nonspecific background hybridization.
Northern Blot Analysis
For Northern blot analysis, 10 fig of total cellular RNA were size fractionated on 1.1% agarose gels containing 40 mM morpholinopropanesulfonic acid, pH 7.4, 10 mM Na acetate, 1 mM EDTA, and 2.2 M formaldehyde. 29 The RNA was electrophoretically transferred to Nytran membranes (Schleicher and Schuell, Inc.) using the procedures recommended by the manufacturer. Filters were baked for 2 hours and hybridized with the synthetic probes using the conditions described above.
Results
Untreated thyroidectomized rats showed no significant change in heart weight:body weight ratio throughout the duration of these experiments ( Figure  1) . Both low and high dosages of thyroid hormone caused a rapid increase in this ratio, which was evident by the second day of treatment. While the amount of ventricular weight gain during the first week of treatment was similar at both dosages, the higher dosage ultimately resulted in greater myocardial growth.
With all of the probes used in this study the amount of radioactivity bound increased linearly as increasing amounts of total cellular RNA were applied to the filters up to about 8 fig per spot ( Figure 2 ). In these experiments, total cellular RNA was prepared from tissues known to express each myosin isoform and spotted on nitrocellulose filters in amounts ranging from 0. . Thefi-MHC probe was hybridized to RNA from hypothyroid ventricle. The Fast II a probe was hybridized to RNAfrom soleus after 7 weeks of T 3 administration at this dosage. The Fast lib probe was hybridized to RNAfrom EDL after 1 week ofT 3 treatment at the same dosage. Cardiac and skeletal a-actin probes were hybridized to RNA from hypothyroid ventricle and soleus muscle, respectively. Dot blots were quantitated as described in "Materials and Methods." Values are in means ± SEM of triplicate determinations. In some cases, the SEM is within the diameter of the symbol. • = radioactivity bound to total cellular RNA from various rat muscles. A = nonspecific background radioactivity obtained after hybridization of the probes with similar amounts of total RNA extracted from liver. MHC = myosin heavy chain; T 3 = 3,5,3'-triiodo-L-thyronine; EDL = extensor digitorum longus. steps, the dot blots were quantitated using the procedures outlined in "Materials and Methods." Specifically bound counts were obtained as the difference between total bound radioactivity and counts bound nonspecifically to an equivalent amount of total cellular RNA from liver.
The specificity of the hybridization of synthetic oligonucleotide probes to MHC mRNAs was verified by Northern blot analysis with RNA from ventricle and skeletal muscles of hypothyroid and T 3 -treated animals. Hybridization to blots of size-fractionated total RNA showed that all MHC probes hybridized to a single band with a mobility of about 7,100 nucleotides ( Figure 3 ). This corresponds to the size reported for MHC mRNA. 30 Duplicate samples of RNA prepared from untreated hypothyroid ventricles showed very little hybridization to the a-MHC probe ( Figure 3A whereas the duplicate filter (lane 4) showed much less hybridization of the /3-MHC probe as compared to RNA from the hypothyroid control (lane 3). Some nonspecific binding to 28s and 18s ribosomal RNA was observed. Since this background was only seen in lanes where MHC mRNA was abundant, the nonspecific binding may have been produced by hybridization of the probes to partially degraded MHC mRNAs whose migration through the gel has been retarded by interaction with the more abundant rRNA species. The absence of extensive hybridization by these probes to total RNA prepared from liver is consistent with this interpretation. As indicated in Figure 1 , nonspecifically bound counts always were less than 10% of specifically bound counts and did not interfere with estimations of specific MHC mRNA levels. Northern blot analysis showed hybridization of both the Fast Ua (lane 5) and the Fast lib MHC probes (lane 6) with RNA prepared from hypothyroid EDL ( Figure  3B ). There also was a surprisingly large degree of hybridization to the slow /3-MHC probe (lane 7). The strong signal observed with the /3-MHC probe presumably is caused by a switch in the hypothyroid EDL from fast-to slow-type MHCs.
Northern blot analysis of RNA from hypothyroid soleus ( Figure 3C ) showed a strong hybridization to the /3-MHC probe after 16 hours of exposure of the autoradiogram (lane 10). After longer exposure (96 hours), probes for Fast Ua MHC and Fast lib MHC showed faint hybridization with a band of similar mobility (lanes 8 and 9). Probes for fetal-and embryonic-MHC skeletal mRNAs did not hybridize with MHC mRNAs either before or after T 3 treatment. When analyzed by Northern blot hybridization, both cardiac and skeletal a-actin probes hybridized to a single band of total RNA with a mobility of approximately 1,650 nucleotides (data not shown).
Daily administration of T 3 (2 ^ig/100 g body weight) to hypothyroid rats resulted in changes in the MHC mRNA content of muscle types examined (Figure 4 ). In ventricle, there was a rapid increase in a-MHC mRNA, which began 6-12 hours after treatment, and by 1 day it was increased by 500% over the control value. After 1 week of treatment, a-MHC mRNA had declined from peak values and thereafter remained at about 300% of control. During the first two days of treatment, the levels of /3-MHC mRNA decreased by about 65% and then remained fairly constant.
Another pattern of MHC gene regulation by T 3 was observed in EDL, a predominately fast-twitch muscle (Figure 4 ). Levels of all three mRNAs expressed in this muscle appeared to be regulated by T 3 administration, but in very different ways. As observed in the ventricle, /3-MHC mRNA was repressed by about 40% after 48 hours of treatment and by 50% after 1 week. Fast Ha MHC mRNA was decreased to about 50% of Interesting differences also were noted between expression of the /3-MHC gene in ventricle and soleus, a slow-twitch skeletal muscle that expresses predominantly /3-MHC mRNA (Figure 4 ). Rapid repression of /3-MHC mRNA by T 3 dosing is observed in ventricle, whereas in soleus this mRNA is not repressed significantly even by 9 weeks of treatment. Furthermore, in soleus, T 3 administration stimulates production of Fast Ila MHC mRNA, which has been shown to be produced in a small number of soleus fibers in euthyroid rats. 31 After 7 weeks of daily treatment, Fast Ha is increased by 150% and by 200% after 9 weeks. Binding of a second fast MHC mRNA form, designated as Fast lib, showed smaller increases (60-80%) over the same period.
With minor exceptions, daily administration of larger doses of T 3 (15 /u.g/100 g body weight) produced similar effects on MHC gene expression ( Figure 5 ). a-MHC mRNA was induced only in ventricle and reached levels comparable to those achieved with lower doses. At the higher dosage of T 3 , /3-MHC mRNA was repressed to the same degree in ventricle as with the lower dosage but was inhibited to a greater degree in EDL (75% inhibition versus 50%). In soleus, /3-MHC gene expression was slightly more sensitive to the higher dose of T 3 , as evidenced by a 30% reduction in /8-MHC mRNA after 1 week of treatment. The Fast MHC mRNAs showed similar patterns of regulation. Fast lib MHC mRNA was increased in EDL by 300%, and Fast Ha MHC mRNA was repressed by 60% after 1 week. In soleus, Fast Ila MHC mRNA was induced, but only after 1 week of treatment.
Daily administration of the lower dose of T 3 (2 /xg/100 g body weight) caused accumulation of acardiac actin mRNA to levels 100% and 150% above the control after 1 and 2 days of treatment, respectively, but returned toward control levels after 1 week of treatment ( Figure 6 ). Very little hybridization of the askeletal actin probe with ventricular RNA was observed, and this did not change after T 3 injection (data not shown). Skeletal a-actin levels did not change significantly in either soleus or EDL muscles, and cardiac a-actin mRNA did not appear to be expressed in these muscles.
Discussion
Recently, we have demonstrated the usefulness of synthetic oligonucleotide DNA probes in a simple dotblot assay for studying mRNA expression in a highly conserved multigene family. 7 Evidence was presented to suggest that a low dose of T 3 was able to alter MHC expression in ventricle and soleus muscle in a tissue specific manner. Here we have extended our preliminary findings by examining the effects of two dosage levels of T 3 on the expression of the MHC mRNAs and skeletal and cardiac a-actin mRNAs. The tissues examined included ventricle, soleus (a predominantly slow-twitch muscle), and EDL (a predominantly fasttwitch muscle). The results obtained in this study warrant further discussion in terms of the highly complex and tissue-specific actions of thyroid hormone on MHC and a-actin gene expression.
Although the assay used to measure MHC mRNA levels does not differentiate between changes in transcriptional activity and alterations in mRNA stability, the reciprocal regulation of the same MHC mRNAs in different tissues and the rapid induction of a-MHC Ventricle EDL Soleus FIGURE 5 . Dot-blot analysis of the effects of high-dose thyroid hormone administration (15 fj.g/100 g) on hybridization of synthetic oligonucleotide MHC probes with RNAfrom ventricle and skeletal muscles. The assay was performed as described in Figure 3 . Each point represents the mean ± SEM of triplicate determinations on individual muscles from 4 to 6 animals. EDL = extensor digitorum longus.
Time mRNA from negligible levels in the ventricle are consistent with transcriptional control. The results can be summarized as follows (Figure 7) . First, a-MHC mRNA is regulated by thyroid hormone only in ventricle, and this gene does not appear to be expressed in skeletal muscles. Similarly, the two Fast-MHC mRNAs are controlled by thyroid hormone only in skeletal muscles and are not expressed in ventricle. Secondly, /3-MHC mRNA is induced by hypothyroidism to varying degrees in ventricle and skeletal muscles, and is repressed by thyroid hormone treatment, although not to the same extent in all tissues. It should also be noted that in those tissues where T 3 causes repression of MHC mRNA expression, this process is not complete. Third, both Fast MHC mRNAs are sensitive to thyroid status in skeletal muscles, but in an unexpectedly complex manner. For example, Fast Ila MHC mRNA is induced in soleus by thyroid hormone treatment, but it is repressed in EDL. Finally, a-actin isoform transitions do not occur in response to changes in thyroid status. However, there is a transient increase in the amount of the cardiac isoform of a-actin mRNA during the first two days of T 3 treatment that approximately parallels the increase in a-MHC mRNA. These findings suggest that MHC gene expression is subject to at least two types of regulation. One type involves the stable repression of MHC genes within a particular muscle type. MHC genes repressed in this manner are unresponsive to changes in thyroid status. The second mechanism involves regulation of MHC genes in a manner that allows the gene to respond to changes in thyroid status with either increased or decreased expression. Processes such as tissue-specific DNA methylation might be envisioned in the first type of control, whereas binding of protein activator or repressor molecules to regulatory regions of the responsive genes might underlie the second type of regulation.
Control of /3-MHC gene expression provides an example of the second type of regulation. This gene is constitutively expressed in ventricular, soleus, and EDL muscles in the hypothyroid state. In ventricle and EDL, the /3-MHC gene may be affected by a negative regulatory factor that itself is under the control of thyroid hormone. This putative regulatory factor may be absent, or present only at very low levels, in soleus muscle and may act as a positive regulator of a-MHC synthesis in ventricle. Alternatively, thyroid hormone may repress the expression of a positive regulatory factor that activates /3-MHC expression in the hypothyroid state. The apparently simultaneous activation of the aMHC gene and repression of the /3-MHC gene suggests the existence of a common control mechanism, but independent control of the two genetically linked genes cannot be ruled out.
Any plausible explanation of MHC gene control also must explain the marked difference in time of response to T 3 administration. The delayed onset of T 3 action on Fast Ila MHC mRNA expression, for example, is consistent with earlier results indicating that at least 6 weeks of high-dose thyroid hormone administration are required to increase the proportion of fast oxidative fibers (Ha) in soleus muscle from the normal value of 12% to 26%. 16 The slow onset of T 3 action on Fast Ila MHC mRNA expression in soleus as compared with the rapid effect on a-MHC mRNA accumulation in ventricle might be related to a larger number of T-, nuclear receptors in -SO . ventricle as compared with skeletal muscles. 8 Alternatively, the delay in accumulation of the Fast Ha MHC mRNA in soleus muscle may be related to slower accumulation of an intermediate signal in the steps between binding of T 3 to its nuclear receptors and stimulation of specific genes. 23 The time required to accumulate an essential regulatory factor also might explain the delay in /3-MHC mRNA repression after T 3 dosing in soleus and EDL as compared with ventricle. It should be noted that soleus muscle has not been reported to contain Type lib fibers in either the euthyroid or hyperthyroid state by histological criteria. 15 -l6 Possibly, the histochemical properties designated as Type Ila may reflect the combined ATPase activities of the two myosin isoforms within the same fiber. Different effects of thyroid hormone on the same protein in different tissues have been reported earlier. For example, synthesis of phosphoenolpyruvate kinase has been found to be increased in the liver of hyperthyroid animals, whereas decreased synthesis was found in the kidney, despite similar levels of nuclear occupancy in both organs. 32 Also, the specific activity of mitochondrial a-glycerolphosphate dehydrogenase (aGPDH) has been shown to be affected differently by thyroid hormone in fast and slow skeletal muscles and cardiac muscle of the rat. 33 Increases in the activity of aGPDH were found in soleus and heart after administration of high doses of T 3 , but no changes were observed in the rectus femoris, a fast muscle. The induction of various components of the /3-adrenergic receptor system have also been shown to be differentially regulated by thyroid hormone in a tissue-specific manner. 3435 In most tissues, including heart and adipose tissue, hyperthyroidism increases, and hypothyroidism decreases, synthesis of these proteins, but in liver the opposite pattern is observed. Many hypotheses have been proposed to account for these tissuespecific responses including differences in the entry or conversion of thyroid hormones at the tissue level* and quantitative and/or qualitative differences in the nuclear T 3 receptors. To date, however, little evidence has been presented to support these hypotheses.
Ventricle Cardiac Actin
Although the a-actin mRNAs have been shown to undergo developmental isoform transitions in cardiac and skeletal muscles in the neonatal rat, 22 the present results indicate that isoform transitions are not regulated by thyroid hormone in adult ventricle or skeletal muscles. On the other hand, a transient accumulation of a-cardiac actin was observed in ventricle following thyroid hormone administration, suggesting that the hormone also may modulate the level of expression of other muscle-specific genes. The stimulation of a-actin in ventricle would be consistent with the accumulation of actin related to cardiac growth (Figure 1 ). It is unclear whether this is caused by direct actions of thyroid hormone on the actin gene or by a more general stimulus to growth that might involve a number of muscle protein genes. These effects of thyroid hormone on the expression of muscle-specific proteins other than MHC in the myocardium deserve further study. 
